Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major - Concepedia

Concepedia

Publication | Open Access

Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major

DOI Full Paper Access

420

Citations

26

References

1998

Year

N F Olivieri, Gary M. Brittenham, Christine E. McLaren, Douglas M. Templeton, Ross Cameron, Robert A. McClelland, Alastair D. Burt, K A Fleming

New England Journal of Medicine

Abstract

Deferiprone does not adequately control body iron burden in patients with thalassemia and may worsen hepatic fibrosis.

References

	Year	Citations

Page 1